This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gravitt, P. E. Articles by Schiffman, M. Search for Related Content PubMed PubMed Citation Articles by Gravitt, P. E. Articles by Schiffman, M.

A Comparison between Real-Time Polymerase Chain Reaction and Hybrid Capture 2 for Human Papillomavirus DNA Quantitation¹

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892 [P. E. G., A. H., M. E. S., M. S.]; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205 [P. E. G., K. J. H.]; Albert Einstein College of Medicine, Bronx, New York [R. D. B.]; Digene Diagnostics, Gaithersburg, Maryland [A. L.]; and Proyecto Epidemiologico Guanacaste, Guanacaste, Costa Rica [R. H., M. C. B., A. C. R.]

Studies investigating human papillomavirus (HPV) viral load as a risk factor in the development of squamous intraepithelial lesions (SILs) and cancer have often yielded conflicting results. These studies used a variety of HPV viral quantitation assays [including the commercially available hybrid capture 2 (HC 2) assay], which differ in their ability to account for differences in cervical cell collection, linear dynamic range of viral load quantitation, and determination of type-specific versus cumulative viral load measures. HPV-16 and HPV-18 viral quantitation using real-time PCR assays were performed to determine whether type-specific viral load measurements that adjust for specimen cellularity result in a different association between viral load and prevalent SIL and cancer, compared with HC 2 quantitation (which does not adjust for cellularity or multiple infections). In general, HPV-16 viral load as measured by real-time PCR increased linearly with increasing grade of SIL while HPV-18 measured using similar techniques increased through low-grade SIL (LSIL), with HPV-18 viral load among high-grade SIL and cancers near the level of cytologically normal women. HC 2 viral load, using the clinical 1.0 pg/ml cut point, differentiated cytologically normal women from women with any level of cytological abnormality (normal versus ≥LSIL) but did not change as lesion severity increased. There was no evidence for plateau of HC 2 at high copy numbers, nor was significant variability in total specimen cellularity observed. However, cumulative viral load measurements by HC 2, in the presence of multiple coinfections, overestimated type-specific viral load. Multiple infections were more common among women with no (32%) or LSIL (51%) [versus 23% in high-grade SIL/cancer], partially explaining the lack of a dose response using a cumulative HC2 viral load measure. The nonrandom distribution of multiple infections by case-control status and the apparent differential effect of viral load by genotype warrant caution when using HC 2 measurements to infer viral load associations with SIL and cancer.

This article has been cited by other articles:

				N. Wentzensen, P. E. Gravitt, D. Solomon, C. M. Wheeler, and P. E. Castle A Study of Amplicor Human Papillomavirus DNA Detection in the Atypical Squamous Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion Triage Study Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1341 - 1349. [Abstract] [Full Text] [PDF]

				L. F. Xi, L. A. Koutsky, P. E. Castle, C. M. Wheeler, D. A. Galloway, C. Mao, J. Ho, and N. B. Kiviat Human Papillomavirus Type 18 DNA Load and 2-Year Cumulative Diagnoses of Cervical Intraepithelial Neoplasia Grades 2-3 J Natl Cancer Inst, February 4, 2009; 101(3): 153 - 161. [Abstract] [Full Text] [PDF]

				J. L. K. Cheung, T.-H. Cheung, C. W. Y. Ng, M. Y. Yu, M. C. S. Wong, S.-S. N. Siu, S.-F. Yim, and P. K. S. Chan Analysis of Human Papillomavirus Type 18 Load and Integration Status from Low-Grade Cervical Lesion to Invasive Cervical Cancer J. Clin. Microbiol., February 1, 2009; 47(2): 287 - 293. [Abstract] [Full Text] [PDF]

				P. E. Castle, C. Meyers, S. Alam, and M. J. Conway How Does Tobacco Smoke Contribute to Cervical Carcinogenesis? J. Virol., June 15, 2008; 82(12): 6084 - 6086. [Full Text] [PDF]

				P. E. Gravitt, M. Schiffman, D. Solomon, C. M. Wheeler, and P. E. Castle A Comparison of Linear Array and Hybrid Capture 2 for Detection of Carcinogenic Human Papillomavirus and Cervical Precancer in ASCUS-LSIL Triage Study Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1248 - 1254. [Abstract] [Full Text] [PDF]

				P. E. Castle, P. E. Gravitt, D. Solomon, C. M. Wheeler, and M. Schiffman Comparison of Linear Array and Line Blot Assay for Detection of Human Papillomavirus and Diagnosis of Cervical Precancer and Cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study J. Clin. Microbiol., January 1, 2008; 46(1): 109 - 117. [Abstract] [Full Text] [PDF]

				P. E. Castle, M. Sadorra, F. A.R. Garcia, A. P. Cullen, A. T. Lorincz, A. L. Mitchell, D. Whitby, R. Chuke, and J. R. Kornegay Mouthwash as a Low-Cost and Safe Specimen Transport Medium for Human Papillomavirus DNA Testing of Cervicovaginal Specimens Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 840 - 843. [Abstract] [Full Text] [PDF]

				M. B. Kovacic, P. E. Castle, R. Herrero, M. Schiffman, M. E. Sherman, S. Wacholder, A. C. Rodriguez, M. L. Hutchinson, M. C. Bratti, A. Hildesheim, et al. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res., October 15, 2006; 66(20): 10112 - 10119. [Abstract] [Full Text] [PDF]

				F. Coutlee, D. Rouleau, P. Petignat, G. Ghattas, J. R. Kornegay, P. Schlag, S. Boyle, C. Hankins, S. Vezina, P. Cote, et al. Enhanced Detection and Typing of Human Papillomavirus (HPV) DNA in Anogenital Samples with PGMY Primers and the Linear Array HPV Genotyping Test. J. Clin. Microbiol., June 1, 2006; 44(6): 1998 - 2006. [Abstract] [Full Text] [PDF]

				Y. Wu, Y. Chen, L. Li, G. Yu, Y. He, and Y. Zhang Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China. J. Gen. Virol., May 1, 2006; 87(Pt 5): 1181 - 1188. [Abstract] [Full Text] [PDF]

				A. T. Hesselink, A. J. C. van den Brule, Z. M. A. Groothuismink, M. Molano, J. Berkhof, C. J. L. M. Meijer, and P. J. F. Snijders Comparison of Three Different PCR Methods for Quantifying Human Papillomavirus Type 16 DNA in Cervical Scrape Specimens J. Clin. Microbiol., September 1, 2005; 43(9): 4868 - 4871. [Abstract] [Full Text] [PDF]

				J. Fontaine, P. Gravitt, L.-M. Duh, J. Lefevre, K. Pourreaux, C. Hankins, F. Coutlee, and The Canadian Women's HIV Study Group High Level of Correlation of Human Papillomavirus-16 DNA Viral Load Estimates Generated by Three Real-time PCR Assays Applied on Genital Specimens Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2200 - 2207. [Abstract] [Full Text] [PDF]

				K S Cuschieri, H A Cubie, M W Whitley, G Gilkison, M J Arends, C Graham, and E McGoogan Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study J. Clin. Pathol., September 1, 2005; 58(9): 946 - 950. [Abstract] [Full Text] [PDF]

				P. E. Castle, M. Schiffman, D. R. Scott, M. E. Sherman, A. G. Glass, B. B. Rush, J. E. Schussler, S. Wacholder, and A. T. Lorincz Semiquantitative Human Papillomavirus Type 16 Viral Load and the Prospective Risk of Cervical Precancer and Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1311 - 1314. [Abstract] [Full Text] [PDF]

				M. E. Sherman, S. S. Wang, C. M. Wheeler, L. Rich, P. E. Gravitt, R. Tarone, and M. Schiffman Determinants of Human Papillomavirus Load among Women with Histological Cervical Intraepithelial Neoplasia 3: Dominant Impact of Surrounding Low-Grade Lesions Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1038 - 1044. [Abstract] [Full Text] [PDF]